Neuroscience Education Institute

11/07/2026

Day 2 just wrapped up and Dr. Andrew Cutler is back with The Daily Dose to recap Friday’s must-know clinical moments at NEI Fall Congress. Which session had you taking the most notes? 👇

11/07/2026

Can clinical features help predict who will respond to treatment for depression?

That was the audience question during Mood Disorders Panel Q&A at the 2026 NEI Fall Congress in Colorado Springs. Dr. Andrew Cutler, Kristian Dambrino, DNP, PMHNP-BC, Dr. Stephen M. Stahl, and Dr. Roger McIntyre discuss what may signal treatment response, and what "inadequate response" really means in practice.

11/07/2026

Day 2 of the 2026 NEI Fall Congress is in the books!

Dr. Stephen Stahl introduced a circuit-based approach to psychosis, including the role of muscarinic agonists. Dr. Jonathan Meyer walked through how to recognize depressive mixed states and avoid misdiagnosis. From inspiring sessions from the NEI Faculty to nonstop conversations on the exhibit hall floor, today was a great reminder of what happens when our community comes together.

A big thank you to our attendees for the energy, the questions, and the connections. The exhibit hall was buzzing all day. 📸

11/06/2026

Day 1 of the 2026 NEI Fall Congress is in the books! Catch up on The Daily Dose with Dr. Andrew Cutler, a recap of Thursday’s top clinical stories, from mania misdiagnosis to early LAIs.
Tell us your favorite Day 1 takeaway. 👇

11/06/2026

Day 1 of 2026 NEI Fall Congress is done, and what a start. 🎉

We kicked off in a packed ballroom and dug into glutamatergic therapies for MDD, new ways to think about difficult-to-treat depression, emerging options for bipolar mania, anosognosia as a barrier to care in schizophrenia, and the case for starting long-acting injectables earlier in serious mental illness.

Lots of good questions from the audience and plenty of notes taken. Already looking forward to what tomorrow brings.

11/05/2026

Fall looks good on The Broadmoor! It’s a beautiful day in Colorado Springs, and we’re looking forward to seeing everyone at the 2026 NEI Fall Congress.

11/05/2026

Today at the Child & Adolescent Psychiatry Academy, we explored the complexity of irritability and emotional dysregulation in youth with autism, took a closer look at dopamine receptor blocking agents in pediatrics, and unpacked practical strategies for treating anxiety, restrictive eating, and ADHD in complex cases.

Insightful discussions, real-world clinical pearls, and meaningful connections made throughout the day. And we’re just getting started.

11/04/2026

In this episode, Dr. Andy Cutler and Dr. Lois Choi-Kain review common myths about personality disorders beyond borderline personality disorder (BPD) and what clinicians may miss when they focus on BPD alone. They discuss dimensional approaches to diagnosis, clinical clues that personality pathology may be present alongside other psychiatric conditions, and how challenges in clinical trials shape the evidence base for treatment. Listen now:

In this episode, Dr. Andy Cutler and Dr. Lois Choi-Kain review common myths about personality disorders beyond borderline personality disorder (BPD) and what clinicians may miss when they focus on BPD alone. T

11/02/2026

Last month the FDA granted 510(k) clearance to a prescription digital therapeutic targeting these negative symptoms of schizophrenia in adults with clinically stable positive symptoms. It is intended to complement clinician-managed outpatient care, including antipsychotic therapy. Read more:

Negative symptoms of schizophrenia can persist despite control of positive symptoms, impairing daily functioning and quality of life. The FDA granted 510(k) clearance to a prescription digital therapeutic targeting these symptoms in adults with clinically stable positive symptoms. It is intended to....